Skip to main content

Advertisement

SpringerLink
Log in

A Study on Omentin-1 and Prostate Specific Antigen in Women on Treatment for Polycystic Ovary Syndrome

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Omentin-1 and prostate specific antigen (PSA) are known to be markers of insulin resistance and hyperandrogenism respectively in polycystic ovary syndrome (PCOS). This study aimed to assess the changes in serum omentin-1 and PSA levels in PCOS patients while on treatment. Serum omentin-1, PSA, BMI and Ferriman gallwey score (FG score) were measured in 80 women with PCOS. The subjects were treated depending on their presenting complaints. The parameters were analysed at baseline and after 3 months of treatment viz. lifestyle modification (Group I), oral contraceptive pills (OCP) (Group II), clomiphene citrate (Group III), medroxy progesterone acetate (Group IV) or metformin (Group V) and was compared using paired-t test. Group II showed significant increase in serum omentin-1 (271.7 ± 112.2 vs 378.1 ± 242 ng/ml; P = 0.025) and decrease in serum PSA (0.014 ± 0.02 vs 0.005 ± 0.008 ng/ml; P = 0.027) after 3 cycles of OCP. Group I and IV also showed a decrease in serum PSA while FG score decreased in group II and group III. There was a negative correlation observed between serum omentin-1 and BMI. To conclude, PCOS women showed increase in serum omentin-1 levels after 3 cycles of OCP while serum PSA decreased after 3 months of lifestyle modification or on treatment with OCP or medroxy progesterone acetate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–9.

    Article  CAS  Google Scholar 

  2. Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290:E1253–61.

    Article  CAS  Google Scholar 

  3. Mahde A, Shaker M, Al-Mashhadani Z. Study of omentin1 and other adipokines and hormones in PCOS patients. Oman Med J. 2009;24:108–18.

    PubMed  PubMed Central  Google Scholar 

  4. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun. 2011;408:339–43.

    Article  CAS  Google Scholar 

  5. Ukinc K, Ersoz HO, Erem C, Hacihasanoglu AB. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome. Endocrine. 2009;35:123–9.

    Article  CAS  Google Scholar 

  6. Vural B, Ozkan S, Bodur H. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome? J Obstet Gynaecol Res. 2007;33:166–73.

    Article  CAS  Google Scholar 

  7. Mardanian F, Heidari N. Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome. J Res Med Sci. 2011;16:999–1005.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Escobar-Morreale HF, Serrano-Gotarredona J, Avila S, Villar-Palasí J, Varela C, Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab. 1998;83:2580–4.

    Article  CAS  Google Scholar 

  9. Kuzbari O, Dorais J, Peterson C. Endocrine disorders. Novaks Gynecol. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 1080–6.

    Google Scholar 

  10. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod Oxf Engl. 2004;19:41–7.

    Article  Google Scholar 

  11. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140:815–30.

    Article  CAS  Google Scholar 

  12. Yu H, Diamandis EP. Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem. 1995;41:204–10.

    CAS  PubMed  Google Scholar 

  13. Nagar R, Msalati AA. Changes in serum PSA during normal menstrual cycle. Indian J Clin Biochem IJCB. 2013;28:84–9.

    Article  CAS  Google Scholar 

  14. Guzelmeric K, Seker N, Unal O, Turan C. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill. Gynecol Endocrinol. 2004;19:190–5.

    Article  CAS  Google Scholar 

  15. Escobar-Morreale HF, Avila S, Sancho J. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills. J Clin Endocrinol Metab. 2000;85:2488–92.

    CAS  PubMed  Google Scholar 

  16. Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab. 1997;82:777–80.

    Article  CAS  Google Scholar 

  17. Negri C, Tosi F, Dorizzi R, Fortunato A, Spiazzi GG, Muggeo M, et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab. 2000;85:81–4.

    CAS  PubMed  Google Scholar 

  18. Obiezu CV, Scorilas A, Magklara A, Thornton MH, Wang CY, Stanczyk FZ, et al. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:1558–61.

    Article  CAS  Google Scholar 

  19. Metawie M, El Sarafy T, El-Kattan S, Azab H, El-Biely M. Serum-prostatic specific antigen level as a promising marker in infertile women with polycystic ovarian disease. Middle East Fertil Soc J. 2008;13:28–32.

    Google Scholar 

  20. Rutanen EM, Pekonen F, Mäkinen T. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J Clin Endocrinol Metab. 1988;66:173–80.

    Article  CAS  Google Scholar 

  21. Shaker M, Mashhadani ZIA, Mehdi AA. Effect of treatment with metformin on omentin-1, ghrelin and other biochemical, clinical features in PCOS patients. Oman Med J. 2010;25:289–93.

    PubMed  PubMed Central  Google Scholar 

  22. Tan BK, Adya R, Farhatullah S, Chen J, Lehnert H, Randeva HS. Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes. 2010;59:3023–31.

    Article  CAS  Google Scholar 

  23. Orlik B, Madej P, Owczarek A, Skałba P, Chudek J, Olszanecka-Glinianowicz M. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2014;81:529–35.

    Article  CAS  Google Scholar 

  24. Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med. 2010;20:143–8.

    Article  CAS  Google Scholar 

  25. Choi J-H, Rhee E-J, Kim K-H, Woo H-Y, Lee W-Y, Sung K-C. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol. 2011;165:789–96.

    Article  CAS  Google Scholar 

  26. Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract. 2011;93:21–5.

    Article  CAS  Google Scholar 

  27. Burelli A, Cionini R, Rinaldi E, Benelli E, Fiore E, Canale D, et al. Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome. J Endocrinol Invest. 2006;29:308–12.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

I thank JIPMER for granting permission and intramural funds for conducting this study.

Funding

The study was funded by the institute’s intramural fund.

Author information

Author notes

  1. Anbalagan Anithasri

    Present address: Government Villupuram Medical College, Villupuram, Tamil Nadu, India

Authors and Affiliations

  1. Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India

    Anbalagan Anithasri & Palghat Harihara Ananthanarayanan

  2. Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India

    P. Veena

Authors
  1. Anbalagan Anithasri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Palghat Harihara Ananthanarayanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Veena
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anbalagan Anithasri.

Ethics declarations

Conflict of interest

Dr. Anbalagan Anithasri, Dr. Palghat Harihara Ananthanarayanan and Dr. P. Veena declare that we have no conflict of interest.

Ethical Approval

All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anithasri, A., Ananthanarayanan, P.H. & Veena, P. A Study on Omentin-1 and Prostate Specific Antigen in Women on Treatment for Polycystic Ovary Syndrome. Ind J Clin Biochem 34, 108–114 (2019). https://doi.org/10.1007/s12291-017-0723-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-017-0723-9

Keywords

Search

Navigation